Some patients who recover from typhoid fever continue to shed the causative organism in their stool — either in the convalescent phase or as established chronic carriers. When this carriage is confirmed by positive stool culture, a targeted and prolonged management strategy is required.
Documented convalescent or chronic carriage of enteric fever confirmed by positive stool culture, where susceptibility testing confirms the infecting organism is susceptible to ciprofloxacin. Patients in this setting require a prolonged course of an appropriate oral antimicrobial to clear carriage.
When susceptibility is confirmed, a prolonged oral antibiotic course forms the cornerstone of treatment. Certain concurrent conditions — including a specific concurrent parasitic infection or the presence of structural anatomical factors in the biliary or urinary tract — may require targeted intervention before or alongside antibiotic therapy. The complete protocol, including how these concurrent factors are managed, is available in the full structured regimen.
Patients with documented convalescent or chronic carriage should be treated for a prolonged duration with an appropriate oral antimicrobial.
If the infecting organism is susceptible to ciprofloxacin, the recommended treatment is ciprofloxacin (20 mg/kg/day po in two divided doses) for 28 days.
Concurrent schistosomiasis plays a role in the development of urinary carriage, and should be treated with praziquantel to eradicate Schistosoma spp. prior to initiating antibiotic therapy.
In these patients, surgery (e.g. cholecystectomy) combined with antibiotic therapy may be indicated.
View source ↗